Skip to main content
. 2023 May 3;109(15):1175–1182. doi: 10.1136/heartjnl-2022-322271

Figure 1.

Figure 1

TEMPEST trial design. §May be performed at visit 1 or visit 2 but must be done before randomisation. AE, adverse event; BP, blood pressure; CMR, cardiovascular magnetic resonance; IMP, investigational medicinal product; 31P MRS, phosphorus-31 magnetic resonance spectroscopy; TEMPEST, The Efficacy and Mechanism of Trientine in Patients with Hypertrophic Cardiomyopathy.